Literature DB >> 2624330

Monoclonal antibodies in the diagnosis and treatment of human diseases.

R G Hamilton1.   

Abstract

Monoclonal antibodies are being used as drugs in the diagnosis, prevention, and treatment of human diseases. The discipline of antibody engineering has evolved with modern cellular and molecular biology methods to meet the challenge of producing human monoclonal antibodies for in vivo biotherapy. In this overview, applications of monoclonal antibodies are presented for patients with selected diseases. Second, antibody engineering methods are overviewed from a chronological perspective for the production of therapeutic murine, human-like chimeric and CDR-grafted, and human monoclonal antibodies. Finally, safety considerations are examined for the efficacious use of monoclonal antibodies as diagnosis and therapeutic drugs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2624330

Source DB:  PubMed          Journal:  Ann Biol Clin (Paris)        ISSN: 0003-3898            Impact factor:   0.459


  3 in total

1.  Human anti-mouse antibody response to the injection of murine monoclonal antibodies against IL-6.

Authors:  E Legouffe; J Liautard; J P Gaillard; J F Rossi; J Wijdenes; R Bataille; B Klein; J Brochier
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

Review 2.  Uses and limitations of monoclonal antibodies (MoAbs) in the treatment of malignant disease: a review.

Authors:  J T Kemshead; K Hopkins
Journal:  J R Soc Med       Date:  1993-04       Impact factor: 18.000

3.  Structure based antibody-like peptidomimetics.

Authors:  Ramachandran Murali; Mark I Greene
Journal:  Pharmaceuticals (Basel)       Date:  2012-02-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.